artículo académico

• Cervicovaginal microbiome and natural history of HPV in a longitudinal study.  PLos Pathogens.  16. 2020
• An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening.  Journal of the National Cancer Institute.  111:923-932. 2019
• Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).  Virology.  516:86-101. 2018
• Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans.  PLos Pathogens.  14. 2018
• T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.  PLoS ONE.  13. 2018
• Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18‐Year follow‐up of the Guanacaste cohort.  International Journal of Cancer.  140:1926-1934. 2017
• Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.  Journal of Infectious Diseases.  213:939-947. 2015
• Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.  International Journal of Cancer.  128:597-607. 2011
• Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes.  PLoS ONE.  6:1-16. 2011
• Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years.  Cancer Epidemiology Biomarkers & Prevention.  19:3044-3054. 2010
• Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection.  Cancer Epidemiology Biomarkers & Prevention.  19:1954-1959. 2010
• Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women.  Cancer Research .  66:11070-11076. 2006